We are looking for children 2 to 17 years of age to join a Crohn’s disease (CD) clinical trial to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or gastrointestinal disease (including associated symptoms such as cramping, growth failure, diarrhea, malnutrition and/or joint pain), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the GI clinical research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
